Published in Arthritis Rheum on August 01, 2010
Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology. Ann Rheum Dis (2012) 1.39
Optical imaging of rheumatoid arthritis. Int J Clin Rheumtol (2011) 0.88
Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model. Arthritis Rheumatol (2014) 0.86
Quantitative assessment of synovitis in patients with rheumatoid arthritis using fluorescence optical imaging. Arthritis Res Ther (2013) 0.82
Detection of clinically manifest and silent synovitis in the hands and wrists by fluorescence optical imaging. RMD Open (2015) 0.78
Aberrant axial mineralization precedes spinal ankylosis: a molecular imaging study in ank/ank mice. Arthritis Res Ther (2011) 0.75
Monocytes loaded with indocyanine green as active homing contrast agents permit optical differentiation of infectious and non-infectious inflammation. PLoS One (2013) 0.75
Imaging evaluation of inflammation in the musculoskeletal system: current concepts and perspectives. Skeletal Radiol (2013) 0.75
Epidemiology and genetics of rheumatoid arthritis. Arthritis Res (2002) 3.37
Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis. Acad Radiol (2006) 1.80
Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. J Clin Invest (1985) 1.73
Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: a comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Res Ther (2006) 1.70
Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol (1999) 1.69
Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res (1998) 1.42
Blood volume measurement at the bedside using ICG pulse spectrophotometry. Anesthesiology (1998) 1.37
Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe. Eur J Nucl Med Mol Imaging (2006) 1.21
Finger tendon disease in untreated early rheumatoid arthritis: a comparison of ultrasound and magnetic resonance imaging. Arthritis Rheum (2007) 1.19
Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther (2005) 1.19
Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm. J Biomed Opt (2004) 1.19
Detection of rheumatoid arthritis using non-specific contrast enhanced fluorescence imaging. Acad Radiol (2009) 0.95
Assessment of proximal finger joint inflammation in patients with rheumatoid arthritis, using a novel laser-based imaging technique. Arthritis Rheum (2002) 0.93
Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System. J Transl Med (2008) 0.86
Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science (2003) 4.40
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol (2010) 2.66
Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology (2005) 2.25
Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med (2006) 1.98
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood (2010) 1.76
Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology (2003) 1.72
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol (2004) 1.70
Iron administration before stem cell harvest enables MR imaging tracking after transplantation. Radiology (2013) 1.70
T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur Radiol (2005) 1.69
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo. Cancer Cell (2013) 1.68
Cell tracking with optical imaging. Eur Radiol (2008) 1.47
Differentiation of normal thymus from anterior mediastinal lymphoma and lymphoma recurrence at pediatric PET/CT. Radiology (2011) 1.46
C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development (2005) 1.45
In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol (2004) 1.44
Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur J Nucl Med Mol Imaging (2004) 1.43
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther (2006) 1.41
Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med (2009) 1.41
Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells. Clin Cancer Res (2011) 1.41
Correlation between vacuum phenomenon on CT and fluid on MRI in degenerative disks. AJR Am J Roentgenol (2011) 1.40
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles. Clin Cancer Res (2011) 1.40
Cell labeling with the positive MR contrast agent Gadofluorine M. Eur Radiol (2007) 1.32
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer. J Nucl Med (2009) 1.31
Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation (2005) 1.25
Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res (2005) 1.25
The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells. Contrast Media Mol Imaging (2009) 1.24
Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe. Eur J Nucl Med Mol Imaging (2006) 1.21
Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol (2006) 1.21
Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J (2005) 1.18
Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells. Magn Reson Med (2009) 1.17
Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J (2003) 1.16
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro Oncol (2010) 1.15
Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol. Invest Radiol (2006) 1.12
Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. Am J Surg Pathol (2008) 1.12
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J (2004) 1.10
Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. Oncotarget (2011) 1.10
Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle. J Vis Exp (2011) 1.09
Labeling hESCs and hMSCs with iron oxide nanoparticles for non-invasive in vivo tracking with MR imaging. J Vis Exp (2008) 1.09
MDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma. Clin Cancer Res (2009) 1.07
Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol (2007) 1.06
Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol (2009) 1.05
Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. Radiology (2010) 1.04
High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol (2005) 1.04
Optical imaging of cellular immunotherapy against prostate cancer. Mol Imaging (2009) 1.04
Bone metastases from renal cell carcinoma: patient survival after surgical treatment. BMC Musculoskelet Disord (2010) 1.04
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood (2006) 1.03
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study. J Clin Oncol (2009) 1.03
Technical aspects of MR diffusion imaging of the body. Eur J Radiol (2010) 1.03
MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis. Invest Radiol (2010) 1.02
Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI. Nanomedicine (Lond) (2013) 1.01
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment. J Nucl Med (2011) 1.01
Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact. Mol Imaging Biol (2011) 1.00
The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas. Oncotarget (2011) 1.00
A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration. Acta Neuropathol (2006) 1.00
Diffusion-weighted imaging of bone marrow. Semin Musculoskelet Radiol (2009) 0.99
Aneurysmal bone cysts of soft tissue represent true neoplasms: a report of two cases. J Bone Joint Surg Am (2011) 0.99
Detection of osseous metastases of the spine: comparison of high resolution multi-detector-CT with MRI. Eur J Radiol (2008) 0.99
C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica (2009) 0.98
Assessment of the internal craniocervical ligaments with a new magnetic resonance imaging sequence: three-dimensional turbo spin echo with variable flip-angle distribution (SPACE). Magn Reson Imaging (2009) 0.98
Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways. BMC Cancer (2011) 0.97
Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations. Mol Imaging (2012) 0.97
Highly efficient paramagnetic labelling of embryonic and neuronal stem cells. Eur J Nucl Med Mol Imaging (2003) 0.96
Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase. Cell Transplant (2010) 0.95
Imaging in multiple myeloma. Eur J Radiol (2009) 0.95
Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction. EJNMMI Res (2013) 0.94
Neovascularization and angiogenic factors in advanced human carotid artery stenosis. Circ J (2012) 0.94
Stress fractures presenting as tumours: a retrospective analysis of 22 cases. Int Orthop (2007) 0.94
High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol (2007) 0.93
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol (2007) 0.93
Diffusion and perfusion imaging of bone marrow. Eur J Radiol (2010) 0.93
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study. Pediatr Blood Cancer (2010) 0.92
In vivo differentiation of complementary contrast media at dual-energy CT. Radiology (2012) 0.92
Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats. J Nucl Med (2012) 0.92
Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad Radiol (2005) 0.91
In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label. Mol Imaging (2010) 0.91
Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities. Cancer Res (2010) 0.91